Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00940316
Title Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Care & Hematology Specialists of Chicagoland Arlington Heights Illinois 60005 United States Details
Northwestern University, Northwestern Medical Faculty Foundation Chicago Illinois 60611-3013 United States Details
Hematology/Oncology Associates Chicago Illinois 60611 United States Details
Joliet Oncology-Hematology Associates, Ltd. Joliet Illinois 60435 United States Details
Hope Cancer Center Terre Haute Indiana 47802 United States Details
Cancer Center of Kansas Wichita Kansas 67214 United States Details
Nebraska Methodist Hospital Omaha Nebraska 68114 United States Details
Virtua Memorial (Regional Cancer Care Associates of Mount Holly) Mount Holly New Jersey 08060 United States Details
Mercy Clinic Oncology and Hematology Oklahoma City Oklahoma 73120-9309 United States Details
The Jones Clinic Germantown Tennessee 38138 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field